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Morphometric measurements were extracted from images of zebrafish embryos (48 hpf) for various toxicological endpoints (eye area,
whole-body length, yolk sac size, cardiac abnormalities). Videos were assessed for the following cardiac morphology/functioning
endpoints: enlarged atrium, enlarged ventricle, hemorrhaging, blood regurgitation, cardiostasis, tube heart, unlooped heart,
pericardial blood pooling, and pericardial/periventral edema. A binary (1, 0) system was used to indicate the presence of a specific
condition and the resultant sum was used as a comprehensive indicator of cardiac morphology/functioning output (CA score).
The response addition (RA) model was used to arrive at the predicted mixture response based on single-chemical trials:!"#$%&' &'()*+(' = )&*-.-"/"$0 1 + )&*-.-"/"$0 3 − ()&*-.-"/"$0 1 ∗ )&*-.-"/"$0 3)
where A and B are endpoints from single-chemical exposures
Morphological and Molecular Analysis of the Toxicity of 
Pharmaceutical-Derived Aquatic Contaminants (PPCPs)
Background
Contaminants of emerging concern (CECs) are ubiquitous aquatic
contaminants that include pharmaceuticals and personal care products
(PPCPs). Due to the exponential increase in pharmaceutical consumption in
recent years, pharmaceutical compounds have been detected at elevated
concentrations globally in surface water, finding their way into waterways
primarily through sewage discharges containing un-metabolized drugs
and improper drug disposal. As these medications are specifically designed to
maximize biological activity at low doses, there is increasing concern
that pharmaceutical-derived aquatic contaminants could pose as potential
environmental stressors to non-target organisms.
Due to their relative newness, the toxicological implications of pharmaceutical-
derived aquatic contaminants, especially in complex mixtures, are poorly
understood. Previous research has largely focused on single-chemical
exposures—however, field testing data shows that this is not environmentally
relevant, as waterways often contain a complex mixture of
multiple contaminants. The limited research that has been conducted on the
toxicity of PPCP mixtures has focused almost exclusively on drugs with similar
mechanisms of action—however, this approach does not
account for the inherent diversity in the types of pharmaceutical contaminants
found in waterways and thus presents an oversimplified model. Moreover, the
molecular mechanisms of potential PPCP toxicity are not well understood,
especially for complex PPCP mixtures.
Morphometric Analysis
The overarching objective of this study was to elucidate the toxicological
implications of pharmaceutical-derived aquatic contaminants. Specifically, the
purpose was two-fold: (1) quantitatively characterize toxicological responses
to both single-chemical and mixtures of PPCPs in zebrafish embryos through
morphometric analysis and (2) conduct molecular analysis of PPCP toxicity in
order to better understand potential mechanisms of toxicity.
Thus, the research question was: What are the toxicological implications
of PPCPs both singly and in complex mixtures and can molecular
analysis be applied to this specific class of contaminants for enhanced
understanding of toxicity? It was hypothesized that contaminant
compounds in a mixture would result in an additive toxic effect which could
potentially induce measureable changes on the molecular level.
Triamterene and gemfibrozil are pharmaceutical-derived contaminants that
have been detected at elevated concentrations not just in the Puget Sound but
globally. However, research regarding the aquatic toxicity of triamterene is
nonexistent and very limited for gemfibrozil. The two drugs have distinct
mechanisms of action, making them ideal compounds for accurately
simulating environmental conditions:
Triamterene is a diuretic primarily used to treat hypertension and edema.
Gemfibrozil is a lipid-regulating fibrate used to treat hypertriglyceridemia. 
Purpose
Experimental Compounds
Lipid Analysis Using Thin Layer Chromatography 
Coupled with Flame Ionization Detection (TLC-FID)
Conclusions/Discussion
Implications
§ Triamterene does not induce any 
statistically significant change in 
extracardial endpoints: whole-body 
length, eye area, or yolk sac area. 
§ However, increased cardiac 
abnormalities are observed in a 
dose-dependent manner. 
§ Gemfibrozil induces a dose-
dependent decrease in whole-
body length and eye area as 
well as a converse dose-
dependent increase in yolk sac 
size. 
§ Moreover, gemfibrozil exposure 
induces cardiac abnormalities 
in a dose-dependent manner. 
Single-Chemical Embryonic Exposures Mixtures Embryonic Exposures
§ Results indicate that gemfibrozil and triamterene induce sub-lethal toxic 
effects in zebrafish during embryogenesis. 
§ Increased observed heart physiological abnormalities suggest that 
triamterene is toxic to the developing fish heart, with pericardial blood 
pooling being a sensitive measure of cardiotoxicity.
§ Gemfibrozil induced a similar dose-dependent increase in cardiac defects. 
The gemfibrozil-induced injury phenotype, however, also included 
extracardial abnormalities, with a small eye phenotype (microphthalmia), 
enlarged yolk sac, and a reduced whole-body length. 
o As eye and whole-body length growth are highly linked to embryonic 
development processes, results suggest that gemfibrozil induces a 
developmental delay during zebrafish embryogenesis. 
§ Observed mixture toxicity was consistent with additive toxicity as 
determined by RA model for all toxicological endpoints. 
o However, with yolk sac area, observed toxicity is consistently above 
predicted values for all mixture concentrations—while observed 
values are not significantly different from predicted ones, this trend in 
the data suggests that the drugs may be interacting to produce 
greater than additive toxicity in terms of yolk sac enlargement. 
§ As lipid levels are not altered following triamterene exposure, results suggest 
that triamterene does not interfere with lipid metabolism. 
§ As total percent lipid values are significantly elevated following gemfibrozil 
exposure, results indicate that gemfibrozil blocks lipid metabolism. 
§ Further interpretation suggests that gemfibrozil may be acting through the 
same metabolic pathway in fish as it does in humans but may be having a 
converse effect: instead of increasing lipase activity, it may be inhibiting 
lipase, thereby blocking triglyceride catabolism.
§ Due to distinctive lipid makeup in mixtures-exposed embryos, results suggest 
that triamterene and gemfibrozil may be interacting to produce toxicity 
through a different metabolic pathway than single-chemical exposures. 
Terminal Injury Phenotypes of Exposed Embryos
§ While experimental concentrations were not consistent with 
environmentally detected levels, results indicate that PPCPs pose as 
environmental stressors for non-target organisms. 
§ Morphometric analysis revealed sub-lethal toxic effects in early life stage 
fish which cannot be detected by crude mortality assays. 
§ Highlights the need for toxicity assays to take into account the effect of 
complex PPCP mixtures in order to more accurately predict environmental 
effects. 
§ Mixture prediction results using RA model indicate that PPCPs with 
different mechanisms of action could induce additive toxic effects and, for 
certain endpoints, potentially metabolically interact to produce synergistic 
toxicity. 
§ TLC-FID method allowed for novel examination of potential molecular 
mechanisms underlying PPCP toxicity. 
§ Lipid analysis suggests that PPCPs could be inducing similar metabolic 
pathways in fish as they do in humans. 
§ Lays the foundation for evidence-based decision-making advocating for 
increased policy regulating the disposal of pharmaceutical waste. 
No observed extracardial
malformations
Cardiotoxic phenotype induction: 
• Structural changes in cardiac 
morphology in severely affected 
embryos
• Pericardial blood pooling/blood 
regurgitation 
• Small eye phenotype
• Reduction in whole   
body length
• Enlarged yolk sac
Cardiotoxic phenotype induction: 
• Cardiac looping defects in select 
embryos
• Pericardial blood pooling/blood 
regurgitation 
• Yolk sac edema at higher 
concentrations
§ Observed mixture toxicity is largely 
consistent with predicted toxicity across 
all concentrations. 
§ However, while not significantly different, 
yolk sac measurements are consistently 
higher than predicted values. 
§ Yolk sac area increases dose-
dependently when gemfibrozil 
concentration is kept constant and 
triamterene concentrations are variable. 
§ Triamterene: Pericardial blood pooling and blood 
regurgitation as well as adverse changes in heart morphology 
are observed at certain concentrations. No abnormalities in 
extracardial endpoints are observed. 
§ Gemfibrozil: Pericardial blood pooling and blood 
regurgitation, looping defects, and yolk sac edema are 
observed at some concentrations. In addition to small eye 
phenotype/reduced length, enlarged yolk sacs are seen, 
suggesting interference with lipid metabolism.
§ Mixtures: Severe cardiac abnormalities are seen at certain 
concentrations, with pericardial blood pooling/blood 
regurgitation and yolk sac edema being prominent indicators 
of toxicity. Reduced eye area and whole-body length as well 
as enlarged yolk sacs are observed across all concentrations. 
Black arrows indicate pericardial blood pooling, white arrows indicate small eye 
phenotype (microphthalmia), and white triangles indicate enlarged yolk sac
Cardiotoxic phenotype induction: 
• Pericardial blood pooling/blood 
regurgitation
• Yolk sac edema in select embryos
Gemfibrozil
Triamterene
§ Lipid levels are significantly elevated following 
single-chemical gemfibrozil exposure. 
§ No significant difference is observed between lipid 
percent values in control embryos and those in 
triamterene and mixtures treated embryos. 
Asterisks denote statistically significantly different 
treatment groups compared to water control values as 
determined by ANOVA one-way test and Tukey-Kramer 
post hoc test
Asterisks denote statistically significantly different 
treatment groups compared to water control values as 
determined by ANOVA one-way test and Tukey-Kramer 
post hoc test
§ Cholesterol and triglyceride levels are significantly 
elevated following gemfibrozil exposure. 
§ Triamterene-exposed embryos do not have significantly 
different cholesterol or triglyceride content as compared 
to water control values.
§ Mixture-exposed embryos show lower triglyceride 
levels and higher cholesterol levels than control 
embryos.
o Lipid composition in mixture-exposed embryos is 
therefore distinct from control embryos. 
Methodology Overview
Embryonic 
Exposures
Embryo 
ImagingOv rarching purpose: Elucidate the toxicological implications of 
pharmaceutical-derived aquatic contaminants
Sub-aim: Characterize toxicological 
response to both single-chemical and 
mixtures of PPCPs
Sub-aim: Conduct molecular 
analysis of PPCP toxicity
Morphometric Analysis Lipid Analysis
Embryonic 
Exposures
Morphometric 
Measurement 
Extraction
Embryo 
Imaging
Thin Layer 
Chromatography
Flame 
Ionization 
Detection
Mixtures Morphometric Measurements
Mixtures
+
Inhibition of 
sodium 
channels
Increased osmolarity
in lumen, decreased 
osmolarity in 
interstitium
Diuresis
Inhibition of 
potassium 
excretion
Triamterene Mechanism of Action (MOA)
Decreased 
osmotic gradient 
for water 
reabsorption
Future Research Directions
Gemfibrozil Mechanism of Action (MOA)
PPAR receptor 
induction 
(agonist)
Increased 
lipase activity 
and synthesis
Increased 
clearance of 
triglycerides 
Triglyceride 
levels reduced; 
cholesterol 
variably reduced
Overall 
decrease in 
lipid levels
• Small eye phenotype
• Reduction in whole   
body length
• Enlarged yolk sac
Triamterene
Dose-dependent cardiotoxicity
No developmental delay during 
embryogenesis
No interference with lipid 
metabolism pathways 
Method Development
Accelerated Solvent 
Extractor Cell 
Sample preparation
• Extracts 
concentrated with 
nitrogen
• Sodium sulfate and 
magnesium sulfate 
used to remove water
Thin Layer 
Chromatography
Lipid Subclass 
Quantification using 
Flame Ionization 
Detection (FID)• Samples spotted on 
Silica Chromarods
• Lipid classes 
separated based on 
polarity in 
chromatography tank
• Embryo composite 
sample packed into 
cell
• Lipids extracted 
using 
dichloromethane
Gemfibrozil
Dose-dependent cardiotoxicity
Developmental delay during 
embryogenesis
Mixtures
+
Potential induction of a distinct 
metabolic pathway separate from 
lipase-mediated pathway. 
Dose-dependent additive 
cardiotoxicity
Developmental delay during 
embryogenesis
• Additive toxicity for eye area and 
whole-body length. 
• Potentially greater than additive 
toxicity for enlarged yolk sac. 
§ Identifying and characterizing which specific metabolic pathway is induced 
by triamterene and gemfibrozil mixtures.
§ Conducting gene expression analysis of exposed embryos using qPCR to 
determine potential genetic markers of toxicity. 
§ Identifying triamterene mechanism of toxicity in fish by specifically 
examining sodium channel function in exposed embryos. 
§ Exposure-linked biomarkers in early life stage fish are next generation 
tools for ecotoxicological assessment—however, they have not yet been 
applied to this specific class of contaminants. Therefore, identifying novel 
molecular biomarkers of toxicity is a viable and promising next step.
PPCP mixtures 
in waterways
Potential 
interference with 
metabolic 
pathways
Sub-lethal 
toxicity 
Environmental 
stressors to 
non-target 
organisms
Largely additive 
toxicity; potential 
for synergism
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